Anaplastic large cell lymphoma and its morphological variants

Cancer Surveys

Volumn 30, Issue , 1997, Pages 77-86

  Kadin, Marshall E ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD30 ANTIGEN;

ANTIGEN ANTIBODY COMPLEX; CANCER STAGING; DISEASE ASSOCIATION; GENE TRANSLOCATION; HETEROCHROMATIN; HODGKIN DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; INCIDENCE; INFLAMMATORY CELL; LARGE CELL LYMPHOMA; PREDICTION; PRIORITY JOURNAL; REVIEW; SEZARY CELL; TUMOR CELL CULTURE;

HUMANS; LYMPHOMA, LARGE-CELL, ANAPLASTIC; LYMPHOMA, LARGE-CELL, KI-1;

EID: 0030800708     PISSN: 02612429     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Agnarsson BA and Kadin ME (1988) Ki-1 positive large cell lymphoma. American Journal of Surgical Pathology 12 264-274
2. Al Saati T, Tkaczuk J, Krissansen G et al. (1996) A novel antigen detected by CBF.78 antibody further distinguishes anaplastic large cell lymphoma from Hodgkin's disease. Blood 88 2741-2746
3. Bitter MA, Franklin WA, Larson RA et al. (1990) Morphology in Ki-1 (CD30)-positive non- Hodgkin's lymphoma is correlated with clinical features and the presence of a unique chromosomal abnormality, t(2;5)(p23;q35). American Journal of Surgical Pathology 14 305-316
4. Chan JKC, Ng CS, Hui PK et al. (1989) Anaplastic large cell Ki-1 lymphoma. Delineation of two morphological types. Histopathology 15 11-34
5. Chan JKC, Buchanan R and Fletcher CDM (1990) Sarcomatoid variant of anaplastic large-cell lymphoma. American Journal of Surgical Pathology 14 983-988
6. Chott A, Kaserer K, Augustin I et al. (1990) Ki-1-positive large cell lymphoma: a clinicopathologic study of 41 cases. American Journal of Surgical Pathology 14 439-448
7. De Cotean JF, Lorenzana A, Kadin ME, Al-Hsmi I, Zielenska M and Freedman M (1995) Identification of candidate autocrine growth factors in Ki-1 (CD30) positive large cell lymphoma cell lines containing the t(2;5) chromosomal translocation. Laboratory Investigation 72 113A
8. Delsol G, Blancher A, Al Saati T et al. (1991) Antibody BNH.9 detects red blood cell-related antigens on anaplastic large cell (CD30+) lymphomas. British Journal of Cancer 64 321
9. Delsol G, Al Saati T, Gatter KC et al. (1988) Coexpression of epithelial membrane antigen (EMA), Ki-1 and interleukin-2 receptor by anaplastic large cell lymphomas. Diagnostic value of so-called "malignant histiocytosis". American Journal of Pathology 130 59
10. Fillipa DA, Ladnayi M, Wollner N et al. (1996) CD30 (Ki-1) positive malignant lymphoma. Clinical, immunophenotypic, histological, genetic characteristics, and differences with Hodgkin's disease. Blood 89 2905-2917
11. Fischer P, Nacheva E, Mason DY et al. (1988) A Ki-1 (CD30)-positive human cell line (Karpas 299) established from a high-grade non-Hodgkin's lymphoma, showing a 2;5 translocation and rearrangement of the T-cell receptor β-chain gene. Blood 72 234-240
12. Greer JP, Kinney MC, Collins RD et al. (1991) Clinical features of 31 patients with Ki-1 anaplastic large-cell lymphoma. Journal of Clinical Oncology 9 539-547
13. Kadin ME (1994) Primary Ki-1-positive anaplastic large-cell lymphoma: a distinct clinicopathologic entity. Annals of Oncology 5 (Supplement 1) 525-530
14. Kadin ME and Wheler CA (1996) Hodgkin's-like anaplastic large cell lymphoma. In: Saven A, Tallman H and Piro L (eds). Oncology Case Study Reports: Focus on Hematological Malignancies, Vol 1, Issue 3, pp. 7-12, ProEd Communications, Cleveland, Ohio
15. Kadin ME, Sako D, Berliner N et al. (1986) Childhood Ki-1 lymphoma presenting with skin lesions and peripheral lymphadenopathy. Blood 68 1042-1049
16. Kinney MC, Collins RD, Greer JP, Whitlock JA, Sioutos N and Kadin ME (1993) A small-cell- predominant variant of primary Ki-1 (CD30)+ T-cell lymphoma. American journal of Surgical Pathology 17 859-868
17. Mann KP, Hall B, Kamino J, Borowitz MJ and Ratech H (1995) Neutrophil-rich, Ki-1-positive anaplastic large-cell malignant lymphoma. American Journal of Surgical Pathology 19 407- 416
18. Marti RM, Wasik MA and Kadin ME (1996) Constitutive secretion of CM-CSF by three different cell lines derived from a single patient with a progressive cutaneous Iymphoproliferative disorder. Cytokine 8 323-329
19. Ming WJ, Bersani L and Mantovani A (1987) Tumor necrosis factor is chemotactic for monocytes and polymorphonuclear leukocytes. Journal of Immunology 138 1469-1474
20. Nakamura S, Takagi N, Kojima M et al. (1991) Clinicopathologic study of large-cell anaplastic lymphoma (Ki-1-positive large cell lymphoma) among Japanese patients. Cancer 68 118- 129
21. Penny RJ, Blaustein JC, Longtine JA and Pinkus GS (1991) Ki-1-positive large cell lymphomas, a heterogeneous group of neoplasms. Morphologic, immunophenotypic, genotypic, and clinical features of 24 cases. Cancer 68 362-373
22. Pileri S, Sabattini E, Poggi S, Amini M, Falini B and Stein H (1994a) Anaplastic large-cell lymphoma, lympho-histiocytic type. Histopathology 25 191-193
23. Pileri S, Bocchia M, Baroni CD et al. (1994b) Anaplastic large cell lymphoma (CD30+/KI-1+): results of a prospective clinico-pathologic study of 69 cases. British Journal of Haematology 86 513-523
24. Reiban J, Meixler S, Lee TC et al. (1991) Transforming growth factor-β1, a potent chemoattractant for human neutrophils, bypasses classic signal-transduction pathways. Proceedings of the National Academy of Sciences of the USA 88 6005-6009
25. Romaguera JE, Manning JT, Tornos CS et al. (1994) Long term prognostic importance of primary Ki-1 (CD30) antigen expression and anaplastic morphology in adult patients with diffuse large-cell lymphoma. Annals of Oncology 5 317-322
26. Sandland JT, Pui C-H and Santana VM (1994) Clinical features and treatment outcome for children with CD30+ large-cell non-Hodgkin's lymphoma. Journal of Clinical Oncology 12 895-898
27. NPM/ALK: a distinct clinicopathologic entity. Blood 86 1954- 1960
28. Shulman LN, Frisard B, Antin JH et al. (1993) Primary Ki-1 anaplastic large-cell lymphoma in adults: clinical characteristics and therapeutic outcome. Journal of Clinical Oncology 11 937-942
29. Stein H, Mason DY, Gerdes J et al. (1985) The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphocytes. Blood 66 848-858
30. Zinzani PL, Bendandi M, Martelli M et al. (1996) Anaplastic large-cell lymphoma: clinical and prognostic evaluation of 90 adult patients. Journal of Clinical Oncology 14 955-962